483 related articles for article (PubMed ID: 17100720)
1. SDF-1 expression is elevated in chronic human renal allograft rejection.
Hoffmann U; Banas B; Krüger B; Banas M; Bergler T; Böger C; Kammerl M; Obed A; Rümmele P; Segerer S; Riegger GA; Krämer BK
Clin Transplant; 2006; 20(6):712-8. PubMed ID: 17100720
[TBL] [Abstract][Full Text] [Related]
2. Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study.
Hoffmann U; Segerer S; Rümmele P; Krüger B; Pietrzyk M; Hofstädter F; Banas B; Krämer BK
Nephrol Dial Transplant; 2006 May; 21(5):1373-81. PubMed ID: 16421159
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of endothelin-1 (ET-1) in human acute renal allograft rejection.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2003; 54(2):95-100. PubMed ID: 14575417
[TBL] [Abstract][Full Text] [Related]
5. DNA fragmentation in acute and chronic rejection after renal transplantation.
Ott U; Aschoff A; Fünfstück R; Jirikowski G; Wolf G
Transplant Proc; 2007; 39(1):73-7. PubMed ID: 17275477
[TBL] [Abstract][Full Text] [Related]
6. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children.
Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW
Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838
[TBL] [Abstract][Full Text] [Related]
7. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M
Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human renal allograft rejection-- a prospective study.
Hoffmann U; Banas B; Krüger B; Pietrzyk M; Obed A; Segerer S; Kammerl M; Rümmele P; Riegger GA; Krämer BK
Transpl Int; 2006 Mar; 19(3):203-12. PubMed ID: 16441769
[TBL] [Abstract][Full Text] [Related]
9. Pancreas allograft rejection: analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies.
Troxell ML; Koslin DB; Norman D; Rayhill S; Mittalhenkle A
Transplantation; 2010 Jul; 90(1):75-84. PubMed ID: 20548259
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the Banff 97 classification of renal allograft biopsies and clinical outcome.
Tanaka T; Kyo M; Kokado Y; Takahara S; Hatori M; Suzuki K; Hasumi M; Toki K; Ichimaru N; Yazawa K; Hanafusa T; Namba Y; Oka K; Moriyama T; Imai E; Okuyama A; Yamanaka H
Transpl Int; 2004 Feb; 17(2):59-64. PubMed ID: 14551678
[TBL] [Abstract][Full Text] [Related]
11. Impact of chemokine receptor CX3CR1 in human renal allograft rejection.
Hoffmann U; Bergler T; Segerer S; Rümmele P; Krüger B; Banas MC; Reinhold S; Banas B; Krämer BK
Transpl Immunol; 2010 Aug; 23(4):204-8. PubMed ID: 20600902
[TBL] [Abstract][Full Text] [Related]
12. Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome.
Vallejos A; Alperovich G; Moreso F; Cañas C; de Lama ME; Gomà M; Fulladosa X; Carrera M; Hueso M; Grinyó JM; Serón D
Nephrol Dial Transplant; 2005 Nov; 20(11):2511-6. PubMed ID: 16077142
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients.
Stallone G; Infante B; Schena A; Battaglia M; Ditonno P; Loverre A; Gesualdo L; Schena FP; Grandaliano G
J Am Soc Nephrol; 2005 Dec; 16(12):3755-62. PubMed ID: 16236802
[TBL] [Abstract][Full Text] [Related]
14. Banff schema for grading liver allograft rejection: utility in clinical practice.
Ormonde DG; de Boer WB; Kierath A; Bell R; Shilkin KB; House AK; Jeffrey GP; Reed WD
Liver Transpl Surg; 1999 Jul; 5(4):261-8. PubMed ID: 10388498
[TBL] [Abstract][Full Text] [Related]
15. [Current topics of the rejection pathology in human renal allografts].
Morozumi K; Fukuda M; Takeda A
Hinyokika Kiyo; 1998 May; 44(5):353-7. PubMed ID: 9656109
[TBL] [Abstract][Full Text] [Related]
16. Role of CXCR3 in cellular but not humoral renal allograft rejection.
Segerer S; Böhmig GA; Exner M; Kerjaschki D; Regele H; Schlöndorff D
Transpl Int; 2005 Jun; 18(6):676-80. PubMed ID: 15910293
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection.
Mengel M; Mueller I; Behrend M; von Wasielewski R; Radermacher J; Schwarz A; Haller H; Kreipe H
Transpl Int; 2004 Jul; 17(6):293-300. PubMed ID: 15221125
[TBL] [Abstract][Full Text] [Related]
18. Effects of hypoxia-inducible factor-1alpha expression and C4d deposition in implantation biopsies on renal allograft.
Kim DJ; Lee S; Kim SJ; Park SG; Kim JS; Hyun SJ; Song YS; Nam ES
Transplant Proc; 2008 Sep; 40(7):2145-6. PubMed ID: 18790175
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane synthase expression in renal transplant patients with rejection.
Ramos EL; Barri YM; Croker BP; Clapp WL; Peterson JC; Wilcox CS
Transplantation; 1995 Feb; 59(4):490-4. PubMed ID: 7878751
[TBL] [Abstract][Full Text] [Related]
20. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
